# Uncomplicated Gonorrhea: Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-gonorrhea-developing-drugs-for-treatment/56891f77-fa9d-4c61-87e8-d129790d9d35

> FDA guidance document: Uncomplicated Gonorrhea: Developing Drugs for Treatment. Issue date: August 18, 2015. Get complete insights and analysis.

---

## Details

- Title: Uncomplicated Gonorrhea: Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-08-18
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0640">FDA-2014-D-0640</a>

## Related Documents

- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)
- [Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/human-immunodeficiency-virus-1-infection-developing-antiretroviral-drugs-for-treatment/29bfce2d-7907-435c-b6f8-596f490430cb)
- [Nonclinical Evaluation of Endocrine-Related Drug Toxicity](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-evaluation-of-endocrine-related-drug-toxicity/3925c81a-41d1-4ab8-a0da-0aec3f634c05)